Substance AbuseSER FamiliaNCT06627764
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families
A study testing SER Familia in people with Substance Abuse and Intimate Partner Violence (IPV), run by Duke University at 1 site in United States.
Trial summary
This study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. Read more about this study
- Who is it for?
- Ages 12 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Substance Abuse, Intimate Partner Violence (IPV), HIV Infections
- What is being tested?
- SER Familia
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 400 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Jun 2025to 31 Jan 2029
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 100 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Eligible participants must identify as Hispanic/Latino/a/x/e,
- be a parent or parental figure with Latin descent
- have a child (Youth) aged 12-17
- speak English and/or Spanish
Who cannot join
- Families planning to move within two years will be excluded
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Duke School of Nursing
Durham, North Carolina, 27707
Rosa Gonzalez-Guarda, PhD, 9196849331, rosa.gonzalez.guarda@duke.edu
Zahira Decena Sanchez, BS, 9196843786, zahira.decenasanchez@duke.edu
About this study
This study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. SER Familia is a six-session intervention co-developed and delivered by community health workers (CHWs) that uses strategies to reduce acculturative stress, promote resilience, improve parent-child and family level health, while simultaneously helping families maintain strong social networks and better navigate community resources to address social determinants of health (SDOH). More specifically, investigators aim to: 1) Examine the efficacy of SER Familia to prevent or reduce the syndemic comprised of substance abuse, IPV, HIV risk, depression, and anxiety among Parents and Youth; and 2) Identify how individual, family, and community mechanisms of change related to acculturative stress and resilience mediates the effect of SER Familia.
- Being tested
- SER Familia
- Keywords
- Family, Stress, Resilience
- Medical subject headings
- Substance-Related Disorders, HIV Infections, Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SER FamiliaBehavioural
SER Familia is a six-session intervention co-developed and delivered by community health workers (CHWs) that uses strategies to reduce acculturative stress, promote resilience, improve parent-child and family level health, while simultaneously helping families maintain strong social networks and better navigate community resources to address social determinants of health (SDOH).
| Study group | Role | What they receive |
|---|---|---|
| Familia SER (Salud, Estrés y Resilencia) Group | Experimental | Participants will attend six intervention sessions. Receives: Behavioral: SER Familia |
| Control Group | No intervention | Participants will not receive SER Familia sessions. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Parent Acculturative stress as measured by the Hispanic Stress Inventory (HSI-2) Immigrant Version
The immigrant version of the HSI-2 includes 10 stress subscales. For each item, participants indicated whether they had experienced the stressor (Yes / No). If participants reported experiencing a stressor, then they rated how stressful the event was on a 5-point Likert scale (1= Not at all worried / tense; 2 = A little worried / tense; 3 = Moderately worried / tense; 4 = Very worried/ tense; 5 = Extremely worried/ tense). The total score ranges from 94 to 470, where a higher score indicates greater stress.
Measured: From Enrollment to end of treatment at 6 weeks
Change in Youth Acculturative stress as measured by the Hispanic Stress Inventory - Adolescent (HSI-A)
The HSI-A includes 8 stress subscales. For each item, participants indicated whether they had experienced the stressor (Yes / No). If participants reported experiencing a stressor, then they rated how stressful the event was on a 5-point Likert scale (1= Not at all worried / tense; 2 = A little worried / tense; 3 = Moderately worried / tense; 4 = Very worried/ tense; 5 = Extremely worried/ tense). The total score ranges from 72 to 360, where a higher score indicates greater stress.
Measured: From Enrollment to end of treatment at 6 weeks
Change in individual resilience as measured by the 25-item Resiliency Scale
The Resiliency Scale uses a 7-point Likert scale to assess how much a respondent agrees or disagrees with statements. The possible total score ranges from 25 to 175, with higher scores indicating greater resilience. Scores above 145 indicate high resilience, 121 to 145 indicate moderate resilience, and below 120 indicate low resilience.
Measured: From Enrollment to end of treatment at 6 weeks
Change in PROMIS (Patient-Reported Outcomes Measurement Information System) Global Health
The PROMIS Global Health score ranges from 10 to 50, where a higher score indicates better overall health.
Measured: From Enrollment to end of treatment at 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Oct 2024
- Study start30 Jun 2025
- Primary completion31 Jul 2028 (estimated)
- Study completion31 Jan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance AbuseStudies of the same condition, open and under way.
- More trials run by Duke UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06627764
- Sponsor's protocol ID
- Pro00114672
- Other IDs
- 1R01MD018920-01A1
- Acronym
- SER Familia
- Status last verified
- Apr 2026
- First submitted
- 3 Oct 2024
- Last updated
- 16 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No